4//SEC Filing
GANNON STEVEN 4
Accession 0000950170-25-073746
CIK 0001582313other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 5:59 PM ET
Size
6.5 KB
Accession
0000950170-25-073746
Insider Transaction Report
Form 4
GANNON STEVEN
Director
Transactions
- Exercise/Conversion
Common Shares
2025-05-14$12.57/sh+5,144$64,660→ 7,144 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-05-14−5,144→ 0 totalExercise: $12.57Exp: 2025-05-20→ Common Shares (5,144 underlying)
Footnotes (1)
- [F1]The shares subject to the option are fully vested and exercisable.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001643085
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 5:59 PM ET
- Size
- 6.5 KB